Setting new standards in information exchange for the pharmaceutical and biotech industry
2014 Sponsors / Exhibitors
Chiltern is a leading, full service, global Contract Research Organization with quality solutions for conducting clinical trials across a broad range of therapeutic areas. Our 1,700+ staff are working across 40+ countries in all types of service models. We strive to be your development partner. For more information, visit www.chiltern.com.
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently has approximately 11,100 employees, operating in 39 countries. Further information is available at www.iconplc.com.
About Aptiv Solutions:
Aptiv Solutions, an ICON plc company, is a recognised leader in the design and execution of adaptive clinical trials for pharmaceutical and biotech customers. The company also has in-depth experience in the management of medical device trials and its Japanese subsidiary, Niphix, is a full-service, oncology-focused CRO serving both Japanese and international customers. For more information, visit www.aptivsolutions.com.
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit visit www.quintiles.com.
AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. 25,000+ registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by the world’s top 20 pharmaceutical, biotech and medical device companies. For more information, visit www.agmednet.com.
A pioneer in clinical trial patient recruitment since 1992, DAC Patient Recruitment Services ― an Imperial company ― offers strategic site selection, customized patient recruitment and retention, award-winning creative services, and CEU-certified clinical staff training. DAC has successfully managed projects impacting over 100,000 patients in 100 countries. For more information, visit www.imperialcrs.com.
iMEDGlobal provides consulting, services, and platforms to life sciences and pharmaceutical clients, addressing critical and complex business and scientific needs. Leveraging deep industry and business process expertise, iMEDGlobal delivers high quality and cost effective solutions across five broad areas: Regulatory Affairs, Clinical Operations, Data Management, Drug Safety and Information Technology. More information is available at www.imedglobal.com.
INC Research is a leading, global full-service clinical research organization (CRO) providing the full range of Phase I to IV clinical development services. As a therapeutically focused CRO, with a Trusted Process® delivery methodology, developing the medicines people need is something we take personally. For more information, please visit www.incresearch.com.
TransPerfect Life Sciences helps life sciences companies conduct clinical development, commercialize and support life cycle management of products on a global scale. We combine our services and 21 CFR Part 11 compliant software to provide global solutions to help life sciences companies operate move to a completely paperless environment. TransPerfect offers end-to-end solutions to support clinical, regulatory, medical affairs, safety, marketing and more. For more information, visit www.trialinteractive.com.
Lambda Therapeutic Research Limited is a leading global Clinical Research Organization (CRO) headquartered in Ahmedabad – India, with facilities and operations in Mumbai (India), Toronto (Canada), Warsaw (Poland), London (UK) and USA. Lambda offers full spectrum clinical trial solutions empowered by more than 14 years of service to the biopharmaceutical and generic industry. For more information, visit www.lambda-cro.com.
PCI partners with pharmaceutical and biotech manufacturers in supporting their global packaging needs throughout the product life cycle — from Phase I clinical trials through commercial launch and ongoing supply — with packaging solutions that increase speed to market and commercial success. To learn more, please visit http://pciservices.com/.
Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives. More information is available at www.big3bio.com.
Now in its 18th Year, BioCentury is recognized as the ESSENTIAL provider of independent, informed business intelligence that regularly affects decisions made by bio-industry leaders and investors throughout the world. BioCentury’s mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, emerging technology, clinical data, public policy and the financing markets. For more information, visit www.Biocentury.com.
BioPharm Clinical is an interactive hub of real-time clinical intelligence, enabling biopharma companies and CROs to assess study feasibility and optimize trial management with essential resources for clinical trial data, global site and investigator
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources. For more information, visit www.bioportfolio.com.
Bloomberg Brief Healthcare Finance delivers unique analysis of the pharmaceutical, biotechnology, medical device and services sectors. Each week, our experts provide extensive coverage of news, trends, and events impacting healthcare companies to help you devise a successful business strategy. For more information, visit www.bloombergbriefs.
CanBiotech is an open innovation platform for the biotechnology and pharmaceutical industries. Source new partners through the CanBiotech portal, participate in our open innovation training workshops in partnership with BioEndeavor and engage CanBiotech and its network of partners to enable open innovation in your organization. Publications include Bio Partnerships Asia©. For more information, visit www.canbiotech.com.
Since 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from top sponsors and CROs to research sites and niche providers, as well as an engaged population of patients interested in clinical research and volunteering. Visit www.centerwatch.com to learn more about our industry-leading news publications, market research and data library, training resources, patient enrollment support, drug intelligence and more.
Clinical Informatics News reports on innovative technologies from clinical trials to medical informatics. Technology continues to permeate all aspects of clinical trials and the patient experience, and the tools to support these efforts are maturing rapidly. ClinicalInformaticsNews.com and the Clinical Informatics News email newsletter provide authoritative news, views, and insights on the vast landscape of innovation between clinical trial management and delivery of care. Subscribe today: www.clinicalinformaticsnews.
Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event’s website and more…If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you’ll find it in www.clocate.com.
HealthEconomics.Com is the world’s most comprehensive and credible website for resources and jobs in healthcare value and market access. It is a top rated Google website in health economics, outcomes research, market access, pricing, and reimbursement resources, conferences, and jobs. A trusted resource, HealthEconomics.Com contains the hottest news, jobs, policy updates, professional development, and education resources, and offers unparalleled advertising opportunities. For more information, visit www.healtheconomics.com.
ICT (International Clinical Trials) magazine provides in-depth comment and analysis on the developments in clinical research for decision makers operating in the field. Each quarterly issue features articles written by key opinion leaders on areas including: clinical research management, eclinical and data solutions, clinical trial supply, and other scientific, operational, and regulatory developments. ICT also presents dedicated sector events, insightful profiles, interviews and reviews; forming an appealing and in-depth guide to the industry. For more information, visit www.samedanltd.com/magazine/13.
Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
For 20 years, Larta Institute has assisted and transformed 3,500 innovations into commercially successful enterprises that positively impact the human good. Our mission and passion is to energize the transformation of ideas into solutions that elevate economic opportunities and make lives better for people around the world. We work side-by-side with entrepreneurs, industries and governments to help them achieve measurable goals and access specialized expertise & resources through a unique Network-Centric model. For more information, visit http://larta.org/.
Life Science Leader focuses on reaching pharma and biotech executives with valuable editorial focused on how they can affect their company’s bottom line. Through case studies, interviews, Q&A’s, and trend articles, topics covered include global clinical trials, funding, emerging market opportunities and drug delivery and development. Your competitors are reading Life Science Leader. Sign up for your complimentary subscription today at www.lifescienceleader.com.
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit www.masslifesciences.com.
The Massachusetts Biotechnology Council (MassBio), a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation’s oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. For more information, visit www.massbio.org.
Medical News Today is the largest independent medical and health news site on the web – with over 2,000,000 unique monthly users it is ranked number one for medical news on Google and Yahoo! Medical News Today is used by Blue Chip pharmaceutical and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted disease/condition and general health campaigns. For more information contact email@example.com or visit www.medicalnewstoday.com.
Medtech Boston aims to highlight exciting innovation work happening in and around the city, and to create starting points for discussion about it. We aim to be as organic and nimble as the kind of work featured in our posts. Ultimately, we want to broadcast what we hope will be a new tradition for Boston, not only as a city with first-class medical research and patient care, but one with passionate people using new technology and creativity to think big thoughts about solutions to some of medicine’s biggest problems. For more information, visit www.medtechboston.medstro.com.
‘Pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.’ For more information, visit www.pharmaphorum.com.
PharmaVOICE magazine, reaching more than 29,000 BPA-qualified life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally, PharmaVOICEMarketplace.com provides a comprehensive directory of products, services, and solutions for the life-sciences industry. To Raise Your VOICE, contact feedback@pharmavoice.
The Rebar Interactive blog is the official blog of Rebar Interactive, a digital strategy company specializing in patient engagement and recruitment for clinical trials. Articles provide unique insights not only on digital strategy and the patient experience, but also on general clinical trial innovation and technology topics. The primary author is Rahlyn Gossen, the founder of Rebar Interactive and a former clinical research coordinator, though various clinical trial experts are invited to guest blog on occasion. For more information, visit www.rebarinteractive.com.
Technology Networks has been established for over 10 years and is now the leading provider of free information services for life science professionals. This includes news, events, posters, videos, webcasts, application notes, new products, a literature search engine and product directories. The information is specifically tailored to over 30 individual communities with specific interests, all of which can be accessed through TechnologyNetworks.com.
Trials is an open access, peer-reviewed, online journal that encompasses all aspects of the performance and findings of randomized controlled trials. We publish articles on general trial methodology as well as protocols, commentaries and traditional results papers – regardless of outcome or significance of findings. The journal encourages full and transparent reporting of all trials. We also benefit from unlimited space, which enables trialists to present a true scientific record of their work. For more information, visit www.trialsjournal.com.